Advertisement

Quality of Life in Hodgkin Lymphoma

  • Teresa V. Halbsguth
  • Hans-Henning FlechtnerEmail author
Chapter
Part of the Hematologic Malignancies book series (HEMATOLOGIC)

Abstract

The long-term cure rates for Hodgkin lymphoma (HL) patients are above 80 % for all stages. Given this impressive long-term outcome for a patient population with a median age of about 30 years at diagnosis, the quality of survivorship has become more and more important. Organ dysfunctions including hypothyroidism, hypogonadism, cardiopulmonary complications, and secondary neoplasia as well as health-related quality of life (HRQoL) are major factors contributing to the patient’s general well-being.

Keywords

Hodgkin Lymphoma Severe Fatigue HRQoL Assessment Hodgkin Lymphoma Patient Impaired HRQoL 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Ganz PA, Moinpour CM, Pauler DK et al (2003) Health status and quality of life in patients with early-stage Hodgkin’s disease treated on Southwest oncology group study 9133. J Clin Oncol 21:3512–3519PubMedCrossRefGoogle Scholar
  2. 2.
    Heutte N, Flechtner HH, Mounier N et al (2009) Quality of life after successful treatment of early-stage Hodgkin’s lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial. Lancet Oncol 10:1160–1170PubMedCrossRefGoogle Scholar
  3. 3.
    U.S. Department of Health and Human Services Food and Drug Administration (2009) Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claimsGoogle Scholar
  4. 4.
    Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRefGoogle Scholar
  5. 5.
    Cella DF, Tulsky DS, Gray G et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMedGoogle Scholar
  6. 6.
    Flechtner H, Ruffer JU, Henry-Amar M et al (1998) Quality of life assessment in Hodgkin’s disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC lymphoma cooperative group. Groupe D’Etude des Lymphomes de L’Adulte and German Hodgkin Study Group. Ann Oncol 9(Suppl 5):S147–S154PubMedCrossRefGoogle Scholar
  7. 7.
    Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR (2002) Methods to explain the clinical significance of health status measures. Mayo Clin Proc 77:371–383PubMedCrossRefGoogle Scholar
  8. 8.
    Bottomley A, Flechtner H, Efficace F et al (2005) Health related quality of life outcomes in cancer clinical trials. Eur J Cancer 41:1697–1709PubMedCrossRefGoogle Scholar
  9. 9.
    Cremeens J, Eiser C, Blades M (2006) Characteristics of health-related self-report measures for children aged three to eight years: a review of the literature. Qual Life Res 15:739–754PubMedCrossRefGoogle Scholar
  10. 10.
    Calaminus G, Doerffel W, Baust K, Teske C, Riepenhausen M, Brämswig J, Flechtner HH, Singer S, Hinz A, Schellong G (2014) Quality of life in long-term survivors following treatment for Hodgkin’s disease during childhood and adolescence in the German multicentre studies between 1978 and 2002. Support Care Cancer 22:1519–1529PubMedCrossRefGoogle Scholar
  11. 11.
    Roper K, McDermott K, Cooley ME, Daley K, Fawcett J (2009) Health-related quality of life in adults with Hodgkin’s disease: the state of the science. Cancer Nurs 32:E1–E17; quiz E18–E19PubMedCrossRefGoogle Scholar
  12. 12.
    Fobair P, Hoppe RT, Bloom J, Cox R, Varghese A, Spiegel D (1986) Psychosocial problems among survivors of Hodgkin’s disease. J Clin Oncol 4:805–814PubMedGoogle Scholar
  13. 13.
    Joly F, Henry-Amar M, Arveux P et al (1996) Late psychosocial sequelae in Hodgkin’s disease survivors: a French population-based case-control study. J Clin Oncol 14:2444–2453PubMedGoogle Scholar
  14. 14.
    Loge JH, Abrahamsen AF, Ekeberg O, Kaasa S (1999) Hodgkin’s disease survivors more fatigued than the general population. J Clin Oncol 17:253–261PubMedGoogle Scholar
  15. 15.
    Wettergren L, Bjorkholm M, Axdorph U, Bowling A, Langius-Eklof A (2003) Individual quality of life in long-term survivors of Hodgkin’s lymphoma – a comparative study. Qual Life Res 12:545–554PubMedCrossRefGoogle Scholar
  16. 16.
    Wettergren L, Bjorkholm M, Axdorph U, Langius-Eklof A (2004) Determinants of health-related quality of life in long-term survivors of Hodgkin’s lymphoma. Qual Life Res 13:1369–1379PubMedCrossRefGoogle Scholar
  17. 17.
    Wettergren L, Bjorkholm M, Langius-Eklof A (2005) Validation of an extended version of the SEIQoL-DW in a cohort of Hodgkin lymphoma survivors. Qual Life Res 14:2329–2333PubMedCrossRefGoogle Scholar
  18. 18.
    Ruffer JU, Flechtner H, Tralls P et al (2003) Fatigue in long-term survivors of Hodgkin’s lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG). Eur J Cancer 39:2179–2186PubMedCrossRefGoogle Scholar
  19. 19.
    Holzner B, Kemmler G, Cella D et al (2004) Normative data for functional assessment of cancer therapy – general scale and its use for the interpretation of quality of life scores in cancer survivors. Acta Oncol 43:153–160PubMedCrossRefGoogle Scholar
  20. 20.
    Hjermstad MJ, Oldervoll L, Fossa SD, Holte H, Jacobsen AB, Loge JH (2006) Quality of life in long-term Hodgkin’s disease survivors with chronic fatigue. Eur J Cancer 42:327–333PubMedCrossRefGoogle Scholar
  21. 21.
    Borchmann P, Muller H, Brillant C et al (2010) Longitudinal evaluation of quality of life and fatigue in Hodgkin lymphoma patients. ASH Ann Meet Abstr 116:935Google Scholar
  22. 22.
    Behringer K, Muller H, Gorgen H et al (2013) Sexual quality of life in Hodgkin lymphoma: a longitudinal analysis by the German Hodgkin Study Group. Br J Cancer 108:49–57PubMedCentralPubMedGoogle Scholar

Copyright information

© Springer International Publishing 2015

Authors and Affiliations

  1. 1.Department of Internal Medicine IUniversity of CologneCologneGermany
  2. 2.Department of Child and Adolescent PsychiatryOtto-von-Guericke-UniversityMagdeburgGermany

Personalised recommendations